chr2-178729703-C-T

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS1

The NM_001267550.2(TTN):​c.18550G>A​(p.Ala6184Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000369 in 1,613,708 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A6184A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00045 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00036 ( 1 hom. )

Consequence

TTN
NM_001267550.2 missense

Scores

3
3
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:4

Conservation

PhyloP100: 7.57

Publications

7 publications found
Variant links:
Genes affected
TTN (HGNC:12403): (titin) This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]
TTN-AS1 (HGNC:44124): (TTN antisense RNA 1) This gene encodes a non-coding RNA transcribed from the opposite strand to the titin gene. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.17472166).
BP6
Variant 2-178729703-C-T is Benign according to our data. Variant chr2-178729703-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 203272.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.000361 (528/1461476) while in subpopulation MID AF = 0.00365 (21/5760). AF 95% confidence interval is 0.00244. There are 1 homozygotes in GnomAdExome4. There are 287 alleles in the male GnomAdExome4 subpopulation. Median coverage is 33. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTNNM_001267550.2 linkc.18550G>A p.Ala6184Thr missense_variant Exon 63 of 363 ENST00000589042.5 NP_001254479.2 A0A0A0MTS7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTNENST00000589042.5 linkc.18550G>A p.Ala6184Thr missense_variant Exon 63 of 363 5 NM_001267550.2 ENSP00000467141.1 A0A0A0MTS7

Frequencies

GnomAD3 genomes
AF:
0.000454
AC:
69
AN:
152114
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00203
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000485
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000403
AC:
100
AN:
248312
AF XY:
0.000460
show subpopulations
Gnomad AFR exome
AF:
0.000129
Gnomad AMR exome
AF:
0.000638
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000928
Gnomad NFE exome
AF:
0.000597
Gnomad OTH exome
AF:
0.000332
GnomAD4 exome
AF:
0.000361
AC:
528
AN:
1461476
Hom.:
1
Cov.:
33
AF XY:
0.000395
AC XY:
287
AN XY:
727012
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33458
American (AMR)
AF:
0.000514
AC:
23
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26120
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39692
South Asian (SAS)
AF:
0.000174
AC:
15
AN:
86252
European-Finnish (FIN)
AF:
0.000300
AC:
16
AN:
53400
Middle Eastern (MID)
AF:
0.00365
AC:
21
AN:
5760
European-Non Finnish (NFE)
AF:
0.000378
AC:
420
AN:
1111712
Other (OTH)
AF:
0.000431
AC:
26
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
40
80
121
161
201
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000447
AC:
68
AN:
152232
Hom.:
1
Cov.:
33
AF XY:
0.000497
AC XY:
37
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.0000481
AC:
2
AN:
41558
American (AMR)
AF:
0.00203
AC:
31
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.0000943
AC:
1
AN:
10610
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000485
AC:
33
AN:
67996
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000424
Hom.:
0
Bravo
AF:
0.000650
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000722
AC:
6
ExAC
AF:
0.000455
AC:
55
EpiCase
AF:
0.000273
EpiControl
AF:
0.000474

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:3Benign:2
May 24, 2021
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 31, 2018
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 29, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 28135719) -

Feb 16, 2024
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TTN: BS1 -

Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Uncertain:1
Dec 19, 2017
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Uncertain:1
Oct 18, 2013
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.A4940T variant (also known as c.14818G>A) is located in coding exon 59 of the TTNgene. This alteration results from a G to A substitution at nucleotide position 14818. The alanine at codon 4940 is replaced by threonine, an amino acid with some similar properties.This variant was previously reported in dbSNP asrs72648947. Based on data from the NHLBI Exome Sequencing Project (ESP), the A-allele has an overall frequency of approximately 0.05% (6/12178), having been observed in0.07% (6/8308)of European American alleles, and not observed in 3870 African American alleles studied.This variant was not reported in the1000 Genomes Project.Based on protein sequence alignment, this amino acidposition is highly conserved in available vertebrate species. In addition, this alteration is predicted to be probably damaging by PolyPhen analysis.Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. -

not specified Benign:1
Jun 13, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: TTN c.14818G>A (p.Ala4940Thr) results in a non-conservative amino acid change located in the I-band region of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00043 in 381852 control chromosomes, predominantly at a frequency of 0.0011 within the Latino subpopulation in the gnomAD database, including 1 homozygote. The observed variant frequency within Latino control individuals in the gnomAD database is approximately 3-fold of the estimated maximal expected allele frequency for a pathogenic variant in TTN causing Dilated Cardiomyopathy phenotype (0.00039), strongly suggesting that the variant is a benign polymorphism. Although the variant, c.14818G>A, has been reported in the literature in cases of sudden unexplained death and catecholaminergic polymorphic ventricular tachycardia (e.g., Campuzano_2015, Sanchez_2016), however without strong evidence for causality. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 26516846, 27930701, 31785789, 28135719). Six ClinVar submitters (evaluation after 2014) have reported the variant with conflicting assessments: 4 submitters classified the variant as VUS, and 2 submitters classified it as likely benign. Based on the evidence outlined above, the variant was classified as likely benign. -

Long QT syndrome Benign:1
Feb 11, 2018
Center for Advanced Laboratory Medicine, UC San Diego Health, University of California San Diego
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
22
DANN
Benign
0.93
Eigen
Pathogenic
0.84
Eigen_PC
Pathogenic
0.72
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.79
T;T;.;T
M_CAP
Benign
0.018
T
MetaRNN
Benign
0.17
T;T;T;T
MetaSVM
Uncertain
0.40
D
PhyloP100
7.6
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-2.0
N;.;.;.
REVEL
Uncertain
0.42
Sift
Benign
0.34
T;.;.;.
Polyphen
1.0
.;.;D;D
Vest4
0.44
MVP
0.46
MPC
0.46
ClinPred
0.056
T
GERP RS
6.2
Mutation Taster
=44/56
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72648947; hg19: chr2-179594430; COSMIC: COSV104645557; API